purdue pharma,

REVERSED 

2100 Computer Architecture and Software 

Ex Parte Marcjan et al 10/403,063 COURTENAY 103(a) LEE & HAYES, PLLC EXAMINER LE, MICHAEL 

AFFIRMED-IN-PART 

1600 Biotechnology and Organic Chemistry 

Ex Parte Lee 10/928,806 SCHEINER 112(1)/112(2)/103(a) FISH & RICHARDSON, PC EXAMINER WHITEMAN, BRIAN A 

"In order to satisfy the written description requirement, the disclosure as originally filed does not have to provide in haec verba support for the claimed subject matter at issue." Purdue Pharma L.P. v. Faulding Inc., 230 F.3d 1320, 1323 (Fed. Cir. 2000). However, the disclosure must convey with reasonable clarity to those skilled in the art that the inventor was in possession of the invention. See id. 

Purdue Pharma L.P. v. Faulding, Inc., 230 F.3d 1320, 56 USPQ2d 1481 (Fed. Cir. 2000) . . . . . . . . . . . . . . . .2163, 2163.05